← Back to search

National Institutes of Health · Department of Health and Human Services

Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)

Opening soon

In short: A grant from National Institutes of Health. Open to many kinds of groups. See who can apply.

Key facts

Deadline
Due about Nov 11, 2026 Estimate, not confirmed by the funder ?
Award size
Not stated: see the official notice
Match ?
Not required · Work out your budget and match
Who can apply
Larger business, Private college or university, Nonprofit without 501(c)(3), City or town government, Small business, County government, Public college or university, School district, Special district (utility, fire, etc.), Tribal government, State government, Nonprofit with 501(c)(3), Tribal organization, and others named in the official notice
Where
Anywhere in the U.S., including Tennessee

Opening soon: the funder has announced this grant, but you can't apply yet. Use the time to get ready and check whether it fits.

Before you apply: federal grants require an active SAM.gov registration (Unique Entity ID) and a Grants.gov account. Registration is free but can take weeks, so start now, not when the deadline is close. Get-ready checklist

How this fits you

  • Available in Davidson County (nationwide program)
  • No match required
  • Past Tennessee awards on file: 127 — including your county

Tell us who you are to see whether you're eligible.

About this grant

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments. Early synthetic lethality–based therapeutic strategies in oncology primarily focused on targeting fixed mutations or genomic abnormalities. More recently, however, it has become clear that clinical benefit is often determined by context-dependent vulnerabilities arising from the intrinsic mutational landscape and adaptive tumor responses. This NOFO is unique in its scope, supporting innovative cancer therapy strategies that explicitly exploit context-dependent effects of radiation therapy (RT) using drug-radiation combinations. The central premise of the PAIRS is that these conditional RT-induced responses can be leveraged to create or enhance actionable vulnerabilities that synergize with molecularly targeted agents for better outcomes. A defining feature of PAIRS is its emphasis on precision, scientific rigor, and reproducibility, aligned with NIH’s scientific priorities. Radiation effects are clinically titratable through advances in delivery accuracy and flexibility, including dose, schedule, and spatial targeting. These capabilities enable the rational design of conditional RT-synthetic combination strategies that preferentially exploit tumor-specific essentialities while sparing normal tissues, thereby enhancing the therapeutic index by optimizing biological response. This NOFO consolidates the prior exploratory/developmental and research project funding opportunities to streamline the application process and maintain momentum in developing approaches that target actionable vulnerabilities within the defined radiation research scope. The applicants may submit either for exploratory/developmental research projects with a project period of up to 2 years or for research projects with a project period of 4 to 5 years.

Who can apply, from the official notice

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).

View on Grants.gov Add dates to my calendar

Ask a partner for a letter

Writing the need statement? Davidson County facts with citations.

Who in Tennessee has won this program

25 awards to Tennessee groups in 2 counties since 1993 · 10 in Davidson County. Largest shown:

Past Tennessee winners
Past winnerWhereAmountFiscal year
St Jude Children's Research Hospital IncMemphis, Shelby County$81.5M1993
St Jude Children's Research Hospital IncMemphis, Shelby County$41.4M1999
St. Jude Children's Research Hospital, Inc.Memphis, Shelby County$14.7M spent that year2025
Vanderbilt UniversityNashville, Davidson County$5.8M2005
University of TennesseeMemphis, Shelby County$5.3M2011
Vanderbilt University Medical CenterNashville, Davidson County$4.1M spent that year2025
St Jude Children's Research Hospital IncMemphis, Shelby County$4M2021
Vanderbilt UniversityNashville, Davidson County$3.9M2023
University of TennesseeMemphis, Shelby County$3.8M2001
St Jude Children's Research Hospital IncMemphis, Shelby County$3.5M2020
Vanderbilt University Medical CenterNashville, Davidson County$3.5M2019
Vanderbilt University Medical CenterNashville, Davidson County$3.4M2006

Source: USAspending.gov; Federal Audit Clearinghouse. Past awards show who this program funds. They don't guarantee future awards.

Tennessee groups that got this money through a state agency or another organization

This federal money also reaches local groups as pass-through grants. 102 pass-through grants on file · 33 in Davidson County. Largest shown:

Tennessee pass-through grant winners
Past winnerWhereThroughAmountFiscal year
St Jude Children's Research Hospital IncMemphis, Shelby CountyUniversity of Southern California$2.8M2023
St Jude Children's Research Hospital IncMemphis, Shelby CountyThe Johns Hopkins University$1.4M2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyBaylor College of Medicine$1.4M2025
St. Jude Children's Research Hospital, Inc.Memphis, Shelby CountyPublic Health Institute$1.1M spent that year2023
St Jude Children's Research Hospital IncMemphis, Shelby CountySeattle Children's Hospital$962K2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyIcahn School of Medicine at Mount Sinai$815K2024
St. Jude Children's Research Hospital, Inc.Memphis, Shelby CountyUniversity of Southern California$811K spent that year2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyUniversity of Southern California$785K2023
Vanderbilt UniversityNashville, Davidson CountyVanderbilt University Medical Center$629K2023
St. Jude Children's Research Hospital, Inc.Memphis, Shelby CountyIcahn School of Medicine at Mt. Sinai$624K spent that year2025
St Jude Children's Research Hospital IncMemphis, Shelby CountyUniversity of California, Los Angeles$501K2024
University of TennesseeMemphis, Shelby CountyUniversity of North Carolina at Chapel Hill$495K2023

Source: USAspending.gov pass-through reports (the first recipient reports each one of $30,000 or more).

More from National Institutes of Health

About the federal program

Cancer Treatment Research
Program number 93.395 (the federal Assistance Listing number) · U.S. Department of Health and Human Services, National Institutes of Health · Cooperative agreement (a grant with close agency involvement), project grant

How applications are judged

The major elements in evaluating applications include assessments of: (1) The scientific merit and general significance of the proposed study and its objectives; (2) the technical adequacy of the experimental design and approach; (3) the competency of the proposed investigator or group to successfully pursue the project; (4) the adequacy of the available and proposed facilities and resources; (5) the necessity of the budget components requested in relation to the proposed project; and (6) the relevance and importance to announced program objectives. The following criteria will be used in considering the scientific and technical merit of SBIR/STTR Phase I grant applications: (1) The soundness and technical merit of the proposed approach; (2) the qualifications of the proposed principal investigator, supporting staff, and consultants; (3) the technological innovation of the proposed research; (4) the potential of the proposed research for commercial application; (5) the appropriateness of the budget requested; (6) the adequacy and suitability of the facilities and research environment; and (7) where applicable, the adequacy of assurances detailing the proposed means for (a) safeguarding human or animal subjects, and/or (b) protecting against or minimizing any adverse effect on the environment. Phase II grant applications will be reviewed based upon the following criteria: (1) The degree to which the Phase I objectives were met and feasibility demonstrated; (2) the...

Match

None required (federal program listing).

This program on SAM.gov

Something wrong on this page? Tell us
What's wrong?

Source: Federal grants from Grants.gov · the official federal record. Last checked by GrantMe Oct 9, 2026.

Reference numbers: official notice number PAR-26-152 · program number 93.395